Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure

European Journal of Clinical Pharmacology

Volumn 54, Issue 3, 1998, Pages 209-214

  Kinugawa, T ^a   Kato, M ^a   Mori, M ^a   Endo, A ^a   Kato, T ^a   Hamada, T ^a   Noguchi, N ^a   Omodani, H ^a   Osaki, S ^a   Ogino, K ^a   Miyakoda, H ^a   Hisatome, I ^a   Shigemasa, C ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Alacepril; Baroreflex sensitivity

Indexed keywords

ADRENALIN; ALACEPRIL; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; ISOSORBIDE DINITRATE; NORADRENALIN; PHENYLEPHRINE; RENIN;

AGED; ARTICLE; BLOOD PRESSURE; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DRUG EFFECT; FEMALE; HEAD TILTING; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYMPATHETIC TONE;

AGED; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIES; ATRIAL NATRIURETIC FACTOR; BAROREFLEX; BLOOD PRESSURE; BODY WEIGHT; CAPTOPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; RENIN; TILT-TABLE TEST; VENTRICULAR FUNCTION, LEFT;

EID: 14444286698     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050447     Document Type: Article

References (27)

1. Koharu K, Hara-Nakamura N, Takeda Y, Iwata T, Ochi T, Kukita H, Muneta S, Hiwada K (1996) Effect of alacepril on 24-hour blood pressure in elderly hypertensive patients. Int J Clin Pharmacol Ther 34: 380-383
2. Kono T (1983) Effects of a new angiotensin-converting enzyme inhibitor, 1-(D-3-acetylthio-2-methylpropanoyl)-L-propyl-L-phenylalanine, in normal men. Jpn Arch Intern Med 30: 415-421
3. Minato H, Hosoki K, Hayashi K, Sawayama T, Kadokawa T, Hashimoto M (1989) Antihypertensive mechanism of alacepril. Effects of its metabolites on the peripheral sympathetic nervous system. Arzneimittelforshung 39: 319-324
4. Kinugawa T, Kitamura H, Noguchi N, Matsumoto T, Saitoh M, Ogino K, Miyakoda H, Kotake H, Mashiba H (1992) Effect of alacepril on blood pressure and neurohumoral factors at rest and during dynamic exercise in patients with essential hypertension. Br J Clin Pharmacol 34: 366-369
5. Kato K, Yasuda T, Sugimoto T, Iizima M, Hosoda S, Kimata S, Nakamura T, Sato T, Kouno T, Takahata Y, Mizuno K, Sasayama S, Kawai C, Kumada T, Kusukawa R, Toshima H, Nakazima M (1995) Clinical efficacy of alacepril (DU-1219) for patients with chronic heart failure. A dose finding study by a multicenter double-blind comparison study. J Clin Therapeut Med 11: 2531-2555 (in Japanese, abstract in English)
6. Francis GS, Goldsmith SR, Levine TB, Olivari MR, Cohn JN (1984) The neurohumoral axis in consestive heart failure. Ann Intern Med 101: 370-377
7. Cody RJ, Franklin KW, Kluger J, Laragh JH (1982) Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition. Circulation 66: 135-142
8. Levine TB, Francis GS, Goldsmith SR, Colin JN (1983) The neurohumoral and hacemodynamic response to orthostatic tilt in patients with congestive heart failure. Circulation 67: 1070-1075
9. Kubo SH, Clark M, Luragh JH, Borer JS, Cody RJ (1987) Identification of normal neurohormonal activity in mild congestive heart failure and stimulation effect of upright posture and diuretics. Am J Cardiol 60: 1322-1328
10. Goldsmith SR (1991) Impaired suppression of plasma norepinephrine during head-down tilt in patients with congestive heart failure. Am Heart J 122: 104-107
11. Hirsch AT, Dzau VJ, Creager MA (1987) Baroreceptor function in congestive heart failure: ellect on neurohumoral activation and regional vascular resistance. Circulation 75 [Suppl IV]: 36-48
12. Kinugawa T, Thames MD (1995) Baroreflexes in heart failure. In: McCall D, Rahimtoola SH (eds) Heart failure Chapman & Hall, New York. pp 30-45 (Current topics in cardiology)
13. Osterziel KJ, Rührig N, Dietz R, Manthey J, Hecht J, Kübler W (1988) Influence of captopril on the arterial baroreceptor reflex in patients with heart failure. Eur Heart J 9: 1137-1145
14. Osterziel KJ, Dietz R, Schmid W, Mikulaschek K, Manthey J, Kübler W (1990) Angiotensin-converting enzyme inhibition improves vagal reactivity in patients with heart failure. Am Heart J 120: 1120-1129
15. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD (1996) Enalapril augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 27: 358-364
16. Teichholz LH, Kreulen T, Herman MV, Gorlin R (1976) Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 37: 7-11
17. Yoshimura M, Komori T, Nakamshi T, Takahashi H (1993) Estimation of sulphoconjugated catecholamine concentrations in plasma by high-performance liquid chromatography. Ann Clin Biochem 30: 135-141
18. 125I] renin activity Kit. Horumon To Rinsyou 28: 63-64
19. Morimoto T, Aoyama M, Gotoh E, Shionoiri H (1983) A method of radioimmunoassay of plasma angiotensin II using florisil. Folia Endocrinol Jap 59: 215-229 (in Japanese, abstract in English)
20. Ysewijin-Van Brussel KA, De Leenheer AP (1985) Development and evaluation of a radioimmimoassay for Arg 8-vasopressin after extraction with Sep-PaK C18. Clin Chem 31: 861-863
21. Nakao K, Sugawara A, Morii N, Sakamoto M, Suda M, Soneda J, Ban T, Kihara M, Yamori Y, Shimokawa M, Kiso Y, Imura H (1984) Radioimmunoassay for α-human and rat atrial natriuretic peptide. Biochem Biophys Res Commun 124: 815-821
22. Smyth HS, Sleight P, Pickering GW (1969) Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreceptor sensitivity. Circ Res 24: 109-121
23. Mohanty PK, Arrowood JA, Ellenbogen KA, Thames MD (1989) Neurohumoral and haemodynamic effects of lower body negative pressure in patients with congestive heart failure. Am Heart J 118: 78-85
24. Scroop GC, Lower RD (1968) Central pressor effect of angiotensin mediated by parasympathetic nervous system. Nature 220: 1331-1335
25. Lee WB, Ismay MJ, Lumbers ER (1980) Mechanisms by which angiotensin II affects the heart rate of the conscious sheep. Circ Res 47: 286-292
26. Guo GB, Abboud FM (1984) Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol 246: H80-89
27. Joy MD, Lower RD (1970) Evidence that the area postrema mediates the central cardiovascular response to angiotensin II. Nature 228: 1301-1304